Abstract
Relying on national official reports to assess the impact of COVID-19 pandemic on human life faces problems of miscounting due to under-reporting of COVID-19 deaths, inaccurate death registration and inconsistency in classification. The reported mortality is often provided at the national level whilst the outbreaks are localised, resulting in underestimation of the true scale of the impact. This study uses all-cause daily death registrations data provided by the Italian Statistical Office (ISTAT) focusing on the five most severely hit provinces in Italy (Bergamo, Brescia, Cremona, Lodi and Piacenza) and Lombardy region. We calculate excess mortality in 2020 compared to the average of the years 2015-2019 and estimate life expectancy for the first wave of the epidemic and for the rest of the year 2020. The estimated excess deaths show significantly higher mortality than official statistics, particularly during the peak of the epidemic and amongst people aged ≥70 years. For the first wave of the epidemic (1 January to 30 April 2020), life expectancy in the five provinces reduced by 6.2 to 8 and 3.6 to 5.8 years for men and women, respectively. For annual life expectancy in 2020, with regular after-COVID mortality patterns, the years of life lost is equivalent to 2.5 to 4.1 years for men and 1.7. to 2.6 years for women, respectively.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study didn't require any review from the IRB.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred in the manuscript are freely accessible. Data from the Italian National Institute of Statistics are made available on the Istat website: https://www.istat.it/ Data from the Human Mortality Database can be accessed at https://www.mortality.org/
